Rejection, Transplant Completed Phase 2 Trials for Bortezomib (DB00188)

Also known as: Graft Rejection / Transplant rejections / Transplant Rejection / Transplanted organ rejection (disorder) / Graft rejection (finding) / Complication of transplanted organ (disorder)